Treatment with dapagliflozin reduced the risk of death or worsening heart failure by 28% compared with standard of care. Dapagliflozin reduced the risk of death or worsening heart failure (HF ...

Citation: Dapagliflozin found to be safe and effective in elderly patients with heart failure undergoing valve replacement (2025, March 31) retrieved 3 April 2025 from https://medicalxpress.com ...

"Dapagliflozin reduced UACR compared with placebo, although considerable variability was observed among individuals. These variations, which were consistent after re-exposure, underscore the need ...

CHICAGO, IL—High-risk older patients with a history of heart failure (HF) who are undergoing transcatheter aortic valve implantation have better outcomes when taking dapagliflozin, results from the ...